SCHEDULE 13D

Company

Finch Therapeutics Group, Inc.

Filed

April 1, 2021

Accession Number

0000950142-21-001168

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →